Anti-Human CD10 - APC

Leinco Technologies
Product Code: LEI-C305
Product Group: Primary Antibodies
CodeSizePrice
LEI-C305-50ug50 ug£192.00
Quantity:
LEI-C305-100ug100 ug£271.00
Quantity:
LEI-C305-200ug200 ug£409.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: SJ5-1B4
Regulatory Status: RUO
Target Species: Human
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This APC conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
The CD10 antigen is found on cells from subjects with acute B-lymphoid leukemia.3 The antigen is also expressed in various degrees on progenitor B-cells, renal epithelium, fibroblasts, granulocytes, early T-lymphocytes and germinal center cells.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
Allophycocyanin (APC)
Format:
This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
NCBI Gene:
4311
Target:
CD10

References

1. Leukocyte Typing V (1995) Oxford University Press 2. Billings, R. et al. (1978) J. Natl. Cancer Inst. 61:583 3. Ritz, J. et al. (1980) Nature 283:583 4. Foon, K. A. et al. (1982) Blood 60:1 Phycobilliproteins are protected under the following patents: (U.S. patents No. 4,520,110 and 4,542,104, European patent no. 76695, Canadian patent No. 1,179,942 and Australian patent No. 548,440).